Skip to main content
Clinical Trials/IRCT20200122046221N1
IRCT20200122046221N1RecruitingPhase 3

Comparison of the efficacy and side effects of oxytocin + misoprostol with methyl ergonovine (metergin) + misoprostol and misoprostol alone in the excretion of pregnancy products.

Jahrom University of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • tendency toward outpatient treatment
  • gestational age less than 14 week
  • not presence of high risk disease

Exclusion Criteria

  • presence of a major disease
  • the patients who can not tolerate drugs
  • those who get tired from the process of treatment

Investigators

Sponsor
Jahrom University of Medical Sciences

Similar Trials